homocysteine has been researched along with gw0742 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, Y; Wang, HJ; Xiao, GF; Xie, LD; Xu, CS; Xu, SH | 1 |
| Huang, M; Song, H; Wang, K; Xie, L; Xu, C; Xu, S | 1 |
2 other study(ies) available for homocysteine and gw0742
| Article | Year |
|---|---|
PPARδ activation inhibits homocysteine-induced p22(phox) expression in EA.hy926 cells through reactive oxygen species/p38MAPK pathway.
Topics: Antioxidants; Cell Line; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Homocysteine; Humans; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Thiazoles; Time Factors; Up-Regulation | 2014 |
Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway.
Topics: Benzimidazoles; Benzoates; Chemokine CCL2; Gene Expression Regulation; HL-60 Cells; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Inflammation Mediators; NF-kappa B; PPAR delta; Protein Transport; RNA, Messenger; Signal Transduction; Telmisartan; Thiazoles; Vascular Cell Adhesion Molecule-1 | 2014 |